FDA Approved: CUROSURF — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for CUROSURF (poractant alfa) from Chiesi USA, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Drugs mentioned

• Curosurf (poractant alfa)

Snippet

SUPPL AP for CUROSURF (PORACTANT ALFA)